Surgery Partners (SGRY) EBIT (2014 - 2026)

Surgery Partners has disclosed EBIT across 13 years of filings, most recently posting $65.8 million for Q1 2026.

• EBIT for Q1 2026 came in at $65.8 million, up 6.3% year-over-year; the trailing twelve-month figure through Mar 2026 was $393.4 million (up 17.54% YoY), and the FY2025 annual result was $389.5 million, up 11.67% from the prior year.
• EBIT came in at $65.8 million for Q1 2026 at Surgery Partners, down from $110.2 million in the prior quarter.
• In the past five years, EBIT ranged from a high of $127.1 million in Q4 2024 to a low of $46.4 million in Q1 2023.
• The 5-year median for EBIT is $84.8 million (2024), against an average of $86.9 million.
• Across the five-year window, EBIT tumbled 53.78% in 2023 and surged 73.56% in 2025, its largest moves.
• Surgery Partners' EBIT stood at $94.2 million in 2022, then rose by 7.64% to $101.4 million in 2023, then advanced by 25.35% to $127.1 million in 2024, then retreated by 13.3% to $110.2 million in 2025, then slumped by 40.29% to $65.8 million in 2026.
• The last three EBIT figures came in at $65.8 million (Q1 2026), $110.2 million (Q4 2025), and $105.7 million (Q3 2025), per Business Quant data.